Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Regeneron Pharmaceuticals Inc (REGN)

NASDAQ
Symbol
Exchange
Currency
REGNNASDAQUSD
1REGNMilanEUR
REGNFrankfurtEUR
REGNViennaEUR
Currency in USD
Disclaimer
906.54
-0.78(-0.09%)
Closed
Pre Market
910.00+3.46(+0.38%)

REGN Comments

Give the anti-corona spray from marinomed-biotech some VC and invest in a pharma company which is heading to the moon:https://www.investing.com/equities/marinomed-biotech-agStudies are proving that the patented method of marinomed prevents infection with all Corona varietis including mutants. It also prevents other virus infections. They have many patents.  Do some good and get rich
digipharm going to be big check it out
Quick buy call on SNDX pharma with 20% upside cap today..17.5 call option target 5$
EPS forecast is going to 'double' to 16 !! (august earnings) . go go go
Going up !! Target 640!
Whwre you see that
earnings, analists, news, ... read read read
Clinical phae 3 data was just released, showing that 50% dose of REG-COV is also effective, even 12.5% works... This should significantly increase the revenue they can tap from the antibody cure, now that the numbers are surging all over Europe
Heading south, ey?
did we hit bottom yet?
why is it going down for weeks ?
ARKG is buying REGN now to hedge against a correction and sell them to buy more growth stock when that happens. However the valuation is indeed quite attractive.
why is it going down fir weeks ?
477$ is good time to enter IMO.
FDA approved REGN’s Evinacumab!!
buy now thank me later ✅
~470?
 I think 470 is an ideal price to enter. Current price sees okay too but I believe 470 would be the lowest it can possibly go for now
 thanks for your advice
Another disgraceful Goldman Sachs recommendation.
they are the best contrarian indicator :)
very slow progress - too many Red days and drops... there is certainly profit taking and shorting that goes on here.. MORE than you can think.. I am staying away..i like my money in a hole in the ground instead of on this.
Where are the buy orders from Goldman Sachs?REGN is there stock with the most upside target price. The 12-mo target price is USD 793!!WHERE ARE THE BUY ORDERS?
Goldman Sachs has a price target of USD 793!!!Don't know what they try to accomplish. Since I saw that aggressive 60%+ target level the stock price is moving lower!!
Che ne pensate di questa azienda?
14 forward p/e, 10 to 20% revenue growth, massive cash balance, what am I missing it looks like a fantastic deal
Too expensive.
2021 Exepected earnings per share $31vs $27(2019);
2020 first 3 quarters profit $2.3B vs full year 2019 profit $2.1B.
The U.S. Government has acquired the initial supply: enough to treat approx. 300K people over the next few months
partnered with Roche to significantly expand capacity starting in 2021.
usd500 maybe soon in less a month
hourly, weekly and monthly strong sell and it won't come pass 484??? van someone tell me why?
low volume
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.